For Atrial Fibrillation Ablation, Dabigatran Reduces Major Bleeds
Uninterrupted treatment with dabigatran, a non-vitamin K antagonist oral anticoagulant (NOACs), before, during and after ablation to treat atrial fibrillation significantly reduced the incidence of major bleeding events…
Lifestyle Intervention Leads to 10-point Drop in Systolic Blood Pressure
In the first randomized, double-blinded trial of an online behavioral intervention for high blood pressure, participants in web-based lifestyle counseling reduced their systolic blood pressure by 10 mmHg,…
Rivaroxaban Reduces VTE Recurrence Compared with Aspirin
In patients at elevated risk for a recurrence of potentially life-threatening blood clots, a low dose of the oral blood-thinning medication rivaroxaban reduced recurrences more than three-fold compared…
Denosumab Found Safe in Long-Term Trial
A new study provides reassuring information about the short-term and long-term safety of denosumab, a monoclonal antibody that is used to treat postmenopausal osteoporosis.Adverse events that had been…
Study suggests evolucamab alongside statins can significantly cut cholesterol
A new class of cholesterol-lowering drug has been found to help patients cut their risk of cardiovascular disease, stroke and heart attack.In a trial of more than 27,000…